Pharmaceutical

Biotech’s road to recovery with 46% increase in Q1 venture funding

Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.

May 29, 2024 - 04:00
Biotech’s road to recovery with 46% increase in Q1 venture funding
Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.
Read the original article

Tags:

Previous Article

Self-amplifying RNA and vaccine innovation: getting from concept to clinic

Next Article

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Carrying the torch of his slain brother, a Chicago ER doctor struggles against the violence around him

Carrying the torch of his slain brother, a Chicago ER d...

Mar 22, 2023

STAT+: FDA approves first Alzheimer’s therapy shown to clearly slow cognitive decline

STAT+: FDA approves first Alzheimer’s therapy shown to ...

Jul 6, 2023

Advent receives US NIH grant for bronchopulmonary dysplasia therapy

Advent receives US NIH grant for bronchopulmonary dyspl...

Jul 19, 2023